362 related articles for article (PubMed ID: 21859969)
1. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport.
Yamamoto S; Tanigawa H; Li X; Komaru Y; Billheimer JT; Rader DJ
Circulation; 2011 Sep; 124(12):1382-90. PubMed ID: 21859969
[TBL] [Abstract][Full Text] [Related]
2. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.
Annema W; Dikkers A; Freark de Boer J; Gautier T; Rensen PCN; Rader DJ; Tietge UJF
J Lipid Res; 2012 May; 53(5):929-940. PubMed ID: 22383685
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.
Takiguchi S; Ayaori M; Yakushiji E; Nishida T; Nakaya K; Sasaki M; Iizuka M; Uto-Kondo H; Terao Y; Yogo M; Komatsu T; Ogura M; Ikewaki K
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1454-1467. PubMed ID: 29748333
[TBL] [Abstract][Full Text] [Related]
4. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
[TBL] [Abstract][Full Text] [Related]
5. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages.
Duong M; Collins HL; Jin W; Zanotti I; Favari E; Rothblat GH
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):541-7. PubMed ID: 16410457
[TBL] [Abstract][Full Text] [Related]
6. Probucol alleviates atherosclerosis and improves high density lipoprotein function.
Zhong JK; Guo ZG; Li C; Wang ZK; Lai WY; Tu Y
Lipids Health Dis; 2011 Nov; 10():210. PubMed ID: 22078494
[TBL] [Abstract][Full Text] [Related]
7. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.
Ramírez CM; Rotllan N; Vlassov AV; Dávalos A; Li M; Goedeke L; Aranda JF; Cirera-Salinas D; Araldi E; Salerno A; Wanschel A; Zavadil J; Castrillo A; Kim J; Suárez Y; Fernández-Hernando C
Circ Res; 2013 Jun; 112(12):1592-601. PubMed ID: 23519695
[TBL] [Abstract][Full Text] [Related]
8. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
[TBL] [Abstract][Full Text] [Related]
9. Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor.
Bashore AC; Liu M; Key CC; Boudyguina E; Wang X; Carroll CM; Sawyer JK; Mullick AE; Lee RG; Macauley SL; Parks JS
Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1747-1761. PubMed ID: 31167565
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.
Huang L; Fan B; Ma A; Shaul PW; Zhu H
J Lipid Res; 2015 May; 56(5):986-97. PubMed ID: 25761370
[TBL] [Abstract][Full Text] [Related]
11. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.
Wang X; Collins HL; Ranalletta M; Fuki IV; Billheimer JT; Rothblat GH; Tall AR; Rader DJ
J Clin Invest; 2007 Aug; 117(8):2216-24. PubMed ID: 17657311
[TBL] [Abstract][Full Text] [Related]
12. Chitosan Oligosaccharides Attenuate Atherosclerosis and Decrease Non-HDL in ApoE-/- Mice.
Yu Y; Luo T; Liu S; Song G; Han J; Wang Y; Yao S; Feng L; Qin S
J Atheroscler Thromb; 2015; 22(9):926-41. PubMed ID: 25843117
[TBL] [Abstract][Full Text] [Related]
13. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
[TBL] [Abstract][Full Text] [Related]
14. Effects of Astaxanthin on Reverse Cholesterol Transport and Atherosclerosis in Mice.
Zou TB; Zhu SS; Luo F; Li WQ; Sun XR; Wu HF
Biomed Res Int; 2017; 2017():4625932. PubMed ID: 29226138
[TBL] [Abstract][Full Text] [Related]
15. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.
Tanigawa H; Billheimer JT; Tohyama J; Fuki IV; Ng DS; Rothblat GH; Rader DJ
Circulation; 2009 Jul; 120(2):160-9. PubMed ID: 19564558
[TBL] [Abstract][Full Text] [Related]
16. Effect of sulfonylurea agents on reverse cholesterol transport in vitro and vivo.
Terao Y; Ayaori M; Ogura M; Yakushiji E; Uto-Kondo H; Hisada T; Ozasa H; Takiguchi S; Nakaya K; Sasaki M; Komatsu T; Iizuka M; Horii S; Mochizuki S; Yoshimura M; Ikewaki K
J Atheroscler Thromb; 2011; 18(6):513-30. PubMed ID: 21636950
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis.
Arakawa R; Tsujita M; Iwamoto N; Ito-Ohsumi C; Lu R; Wu CA; Shimizu K; Aotsuka T; Kanazawa H; Abe-Dohmae S; Yokoyama S
J Lipid Res; 2009 Nov; 50(11):2299-305. PubMed ID: 19458386
[TBL] [Abstract][Full Text] [Related]
18. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis.
Feng Y; Lievens J; Jacobs F; Hoekstra M; Van Craeyveld E; Gordts SC; Snoeys J; De Geest B
Cardiovasc Res; 2010 Nov; 88(2):376-85. PubMed ID: 20562425
[TBL] [Abstract][Full Text] [Related]
20. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
